Efficacy News and Research

RSS
Lovastatin appears to be safe, effective for children with neurofibromatosis type 1

Lovastatin appears to be safe, effective for children with neurofibromatosis type 1

Benefits and harms vary among atypical antipsychotics for off-label use

Benefits and harms vary among atypical antipsychotics for off-label use

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

22nd Century completes enrollment in X-22 Phase II-B smoking cessation study

Arena, Eisai announce new data from lorcaserin Phase 3 clinical trial program

Arena, Eisai announce new data from lorcaserin Phase 3 clinical trial program

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Positive results from Clermont's non-preserved latanoprost phase III trial on glaucoma

Positive results from Clermont's non-preserved latanoprost phase III trial on glaucoma

Percutaneous hepatic perfusion extends survival time for melanoma patients

Percutaneous hepatic perfusion extends survival time for melanoma patients

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Patrys announced PAT-SM6 has efficacy against multiple myeloma in preclinical trials

Patrys announced PAT-SM6 has efficacy against multiple myeloma in preclinical trials

Drug combo for breast cancer in post-menopausal women shows promise

Drug combo for breast cancer in post-menopausal women shows promise

EMA CHMP adopts positive opinion for Optimer's DIFICLIR to treat C. difficile infection

EMA CHMP adopts positive opinion for Optimer's DIFICLIR to treat C. difficile infection

Combination of everolimus, exemestane holds promise against post-menopausal breast cancer

Combination of everolimus, exemestane holds promise against post-menopausal breast cancer

RegeneRx completes RGN-259 Phase 2 trial on dry eye syndrome

RegeneRx completes RGN-259 Phase 2 trial on dry eye syndrome

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.